Quanterix Corp
(NAS:QTRX)
$
11.06
-0.01 (-0.09%)
Market Cap: 426.08 Mil
Enterprise Value: 169.82 Mil
PE Ratio: 0
PB Ratio: 1.26
GF Score: 71/100 Quanterix Corp at Goldman Sachs Healthcare Conference Transcript
Jun 14, 2023 / 05:40PM GMT
Release Date Price:
$22.72
(-1.22%)
Matthew Carlisle Sykes
Goldman Sachs Group, Inc., Research Division - Research Analyst
Hi, everybody. Good morning. Thanks for joining us. My name is Matt Sykes, the life sciences tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of having senior management team from Quanterix here, Masoud Toloue, CEO and Mike Doyle, CFO. Masoud and Mike, thanks for joining me.
Masoud Toloue
Quanterix Corporation - President, CEO & Director
Thanks for having us, Matt.
Michael A. Doyle
Quanterix Corporation - CFO & Treasurer
Thanks, Matt.
Questions & Answers
Matthew Carlisle Sykes;Masoud Toloue
Goldman Sachs Group, Inc., Research Division - Research Analyst;Quanterix Corporation - President, CEO
Great. Maybe if we could just start out and have you kind of set the stage first, talk about the most recent results and some of the trends you're seeing in your business as we kind of enter the second half of this year.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot